Introduction {#sec0005}
============

Hip fractures are very common and serious events in elderly patients. A significant increase in the incidence of proximal femur fractures has been observed in recent decades, mainly due to the increase of the elderly population, since this incidence progresses with advancing age.[@bib0155] This type of fracture accounts for 84% of bone lesions in people aged over 60 years; it is a public health issue and a major cause of mortality, disability, excessive medical and hospital expenses, and social and family problems in this population.[@bib0160], [@bib0165], [@bib0170]

Fractures of the proximal end of the femur include subtrochanteric and transtrochanteric fractures, as well as those in the femoral neck. Most often, trauma is low-energy and is related to factors such as malnutrition, impaired activities of daily living, decreased visual acuity and reflexes, sarcopenia, and -- particularly -- bone fragility.[@bib0155], [@bib0175], [@bib0180]

In most cases, surgery is indicated. Conservative treatment is chosen in cases of incomplete fractures without displacement or when there are no clinical conditions for surgery. A period between 24 and 48 h after the fracture is considered ideal for the surgical procedure to take place, considering the general health of the patient.[@bib0185], [@bib0190], [@bib0195], [@bib0200], [@bib0205], [@bib0210] Several studies indicate advanced age, physical status, male gender, and delayed treatment as determining factors in mortality.[@bib0180], [@bib0205], [@bib0215] Other factors related to an unfavorable outcome include non-ambulatory condition prior to fracture, cognitive deficiencies, occurrence of a second fracture, low functional level at time of discharge, and lack of bisphosphonates and vitamin D replacement.[@bib0180], [@bib0220]

Because fractures of the proximal end of the femur occur in patients with significant comorbidities and high risk of pre-operative complications, this condition has a high mortality rate when compared with other fractures.[@bib0200], [@bib0205], [@bib0215], [@bib0225] An important indicator in the evaluation of care provided in health institutions, mortality rate can also be used for two other purposes: determining the performance of a hospital over time and monitoring the performance of a number of hospitals.[@bib0230]

Given the importance of this issue, this study aimed to determine the mortality rate in the first year of follow-up of elderly patients with hip fracture who underwent surgery at the university hospital of this institution and to identify the comorbidities associated with these patients.

Material and methods {#sec0010}
====================

This was a retrospective study conducted at the university hospital of this institution. The study included elderly patients (65 years or older) admitted with a fracture of the proximal end of the femur and surgically treated from January 2012 to August 2013.

This study was approved by the Research Ethics Committee of the institution. The research followed the recommendations of Resolution No. 196/96 of the National Health Council for Research in Human Beings, and was approved on 1/10/13 (CAAE: 21388913.1.0000.5349). Thus, no information that could identify individuals involved in the research will be published, ensuring the anonymity of the subjects and the privacy of information.

The survey was conducted through a review of medical records and telephone contact with patients and their relatives. The information on death and its date were obtained through telephone contact or through the Canoas Health Department, when direct contact was not possible. Patients whose medical records were incomplete or who died prior to surgical treatment were excluded. Patients who underwent conservative treatment were not included.

The following variables were studied: age, sex, comorbidities, type of fracture, surgical procedure, type of implant used, mean time between fracture and surgery, postoperative complications, and death. The cause of death was not assessed, as it had already been identified in a study conducted earlier in this service and because in most cases the cause of death was not directly related to the surgical procedure.

Data were analyzed with tables, descriptive statistics, and chi-squared and Fisher\'s exact tests, using SPSS software, version 13.0. A maximum significance level of 5% (*p* ≤ 0.05) was considered to be significant. The chi-squared test was used to assess the gender and age prevalence between groups, as well as the number of comorbidities. The other variables were evaluated using Fisher\'s exact and chi-squared tests.

Results {#sec0015}
=======

From January 2012 to August 2013, the medical records of 213 patients with fractures of the proximal end of the femur were selected for inclusion in the study. Of these, 12 were excluded due to incomplete medical records and two due to death prior to the surgery, which resulted in a final sample of 199 patients. Of the total sample, 153 were contacted directly and 46 through the Department of Health system;

47 (23.6%) patients died within a year and 152 (76.4%) remained alive. [Table 1](#tbl0005){ref-type="table"} shows the comparison between the survival group and death group according to age and gender of patients. The survival group was significantly associated with age 65--75 years; conversely, the death group was associated with age range of over 86 years (*p* = 0.021). There was no difference between groups regarding sex (*p* = 0.849).

Regarding the number of comorbidities per patient, it is observed that the presence of no comorbidities was associated with the survival group and that the presence of three comorbidities was associated with the death group (*p* = 0.004; [Table 2](#tbl0010){ref-type="table"}). Two comorbidities were significantly associated with the death group: dementia (*p* = 0.041) and anemia (*p* = 0.000; [Table 3](#tbl0015){ref-type="table"}).

The most prevalent fracture in the study group was transtrochanteric (56.8%), followed by femoral neck (37.7%) and subtrochanteric fractures (5%). Among the osteosynthesis implants, the most widely used was the dynamic hip screw, in 42.7% of cases. [Table 4](#tbl0020){ref-type="table"} indicates that three variables were associated with both groups: time between fracture and discharge (*p* = 0.018), time between surgery and discharge (*p* = 0.003), and osteosynthesis implant (*p* = 0.011). Regarding the variable of time between fracture and discharge, it was observed that the survival group was significantly associated with time \<15 days and the death group, with time \>30 days (*p* = 0.018). In the variable of time between surgery and discharge, the survival group was associated with time \<7 days and the death group, with time 8--15 days and \>15 days (*p* = 0.003). As for the implant used for osteosynthesis, dynamic hip screw was significantly associated with the survival group, and cemented partial hip prosthesis, with the death group (*p* = 0.011).

Regarding complications, sepsis in the postoperative period was significantly associated with the death group (*p* = 0.001). Among other comorbidities studied, there was no significant relationship with the death group ([Table 5](#tbl0025){ref-type="table"}).

Discussion {#sec0020}
==========

This study investigated the mortality of elderly patients who underwent surgery for fractures of the proximal end of the femur after one year of follow-up. The results showed a mortality rate of 23.6%, associated with variables such as age, comorbidities, osteosynthesis, time between fracture and discharge, and time between surgery and discharge.

By presenting these data, the authors aim to encourage the improvement of the quality of the current services, initially by making health officials, hospital administrators, doctors, and other professionals aware of the real problem that these conditions represent.

A higher incidence was observed in female patients (74.4%); this finding is consistent with the literature, which indicates a ratio of two to five women for every man.[@bib0155], [@bib0165], [@bib0170], [@bib0175], [@bib0195], [@bib0215], [@bib0225], [@bib0230], [@bib0235], [@bib0240], [@bib0245], [@bib0250], [@bib0255] The mean age of patients included in the study was 79.84 years, similar to that found in the literature.[@bib0155], [@bib0165], [@bib0235], [@bib0255], [@bib0260]

One-year mortality rates show great variability in the literature.[@bib0160], [@bib0210], [@bib0235], [@bib0240], [@bib0245], [@bib0250] The mortality rate in the present study was 23.6%. Ricci et al.[@bib0250] analyzed 202 patients and observed a mortality rate of 28.7% after one year of follow-up. In turn, Pereira et al.[@bib0240] observed a rate of 35% in a sample of 246 patients with hip fracture. In a study conducted in Italy, Meessen et al.,[@bib0265] with a sample of 828 patients, observed a mortality rate of only 20.7%.

In the present study, it was observed that mortality rate was higher in patients older than 86 years. Pugely et al.,[@bib0270] in a prospective study of 4331 patients, showed a similar increase in mortality in patients over 80 years with hip fracture, which was significant for their overall mortality rate.

The most prevalent comorbidities were hypertension, diabetes mellitus, heart disease, stroke, anemia, and dementia. This profile is consistent with that observed in several studies, in accordance to natural aging process.[@bib0155], [@bib0195], [@bib0230], [@bib0235], [@bib0270] Although hypertension and diabetes mellitus combined accounted for over 80% of prevalence, these comorbidities are not determinant of an unfavorable outcome. Anemia and dementia were significantly associated with the death group, and are mentioned in the literature as factors associated with increased morbidity and mortality.[@bib0250], [@bib0275], [@bib0280], [@bib0285], [@bib0290] In the present study, an increase was observed in mortality among patients with three comorbidities prior to the fracture. Studies show that the number of previous diseases influences the mortality of patients with proximal end of femur fractures and that the presence of two or more comorbidities is associated with increased morbidity and mortality.[@bib0295]

The ideal time between fracture and surgical treatment has been widely discussed in the literature. The ideal time for surgery is considered to be between 24 and 48 h after fracture.[@bib0195], [@bib0200], [@bib0205], [@bib0210], [@bib0225], [@bib0235], [@bib0260] In the present study, the mean interval from fracture to surgery was 16.19 days, with a minimum of two and maximum of 100 days. Despite the disagreement with the literature, the death group was not associated with delay of surgery. As this is a tertiary hospital, there is a bias regarding time between fracture and surgery. As this hospital does not have an emergency care unit, patients are first treated at an emergency department and only after stabilization transferred to the definitive treatment. The authors believe that this generates a significant bias in the outcome of these patients, since the treatment is rarely performed in its ideal form due to the system itself.

Time between fracture and discharge was significant in this analysis. Patients who remained hospitalized for over 30 days presented a higher mortality rate. Astur et al.[@bib0165] reported an increase in mortality of more than five times in patients who were hospitalized for over ten days when compared with those who remained less than ten days. The time between surgery and discharge was statistically significant in the analysis, but this relationship was not observed in the literature.

Osteosynthesis was shown to be relevant to survival and mortality of patients. The use of dynamic hip screws was significantly associated with the survival group. The literature, however, does not indicate a difference between the type of implant used and the mortality of patients with proximal femoral fractures.[@bib0240], [@bib0255]

Regarding complications, only 10% were linked to surgery and the osteosynthesis implant used. The most prevalent clinical complications were urinary tract infection (10.1%), nosocomial pneumonia (8.5%), sepsis (5.5%), and delirium (5.5%), all frequently cited in the literature.[@bib0200], [@bib0215], [@bib0220], [@bib0230], [@bib0270] Sepsis was significantly associated with the death group (*p* = 0.001). In a study published in 2014, Gibson et al.[@bib0300] demonstrated that one-third of patients with proximal femoral fracture admitted to the intensive care unit with sepsis died in the unit and another one-third died outside the unit before discharge.

Conclusion {#sec0025}
==========

In this sample of patients with hip fracture who underwent surgery, the mortality rate at one year was 23.6%; the major comorbidities significantly associated with this outcome were anemia and dementia.
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###### 

Comparison between the survival and death groups to sex and age of patients.

Table 1

  Variable   Group   *p*[a](#tblfn0005){ref-type="table-fn"}                             
  ---------- ------- ----------------------------------------- ----- ------ ----- ------ -------
  *Sex*                                                                                  
   Female    34      72.3                                      114   75     148   74.4   0.849
   Male      13      27.7                                      38    25     51    25.6   
                                                                                         
  *Age*                                                                                  
   65--75    9       19.1                                      54    35.5   63    31.7   0.21
   76--86    20      42.6                                      67    44.1   87    43.7   
   Over 86   18      38.3                                      31    20.4   49    24.6   

*Source*: Authors.

Chi-squared test.

###### 

Comparison between the survival and death groups according to the number of comorbidities presented.

Table 2

  Nο⋅ of comorbidities   Group   *p*[a](#tblfn0010){ref-type="table-fn"}                             
  ---------------------- ------- ----------------------------------------- ----- ------ ----- ------ -----
  None                   1       2.1                                       32    21.1   33    16.6   0.4
  One                    13      27.7                                      45    29.6   58    29.1   
  Two                    14      29.8                                      47    30.9   61    30.7   
  Three                  16      34                                        22    14.5   38    19.1   
  More than three        3       6.4                                       6     3.9    9     4.5    
  Total                  47      100                                       152   100    199   100    

Source: Authors.

Chi-squared test.

###### 

Comparison between the survival and death groups according to the presence of comorbidities.

Table 3

  Comorbidities         Group   *p*[a](#tblfn0015){ref-type="table-fn"}                            
  --------------------- ------- ----------------------------------------- ---- ------ ----- ------ -------
  DM                    13      27.7                                      35   23     48    24.1   0.560
  SAH                   33      70.2                                      92   60.5   125   62.8   0.300
  Stroke                8       17                                        11   7.2    19    9.5    0.53
  NIHD                  7       14.9                                      18   11.8   25    12.6   0.616
  IHD                   5       10.6                                      5    3.3    10    5      0.58
  Dementia              8       17                                        10   6.6    18    9      0.41
  Depression            4       8.5                                       4    2.6    8     4      0.91
  COPD                  1       2.1                                       4    2.6    5     2.5    1.000
  CRF                   2       4.3                                       4    2.6    6     3      0.628
  Neoplasia             2       4.3                                       12   7.9    14    7      0.526
  Anemia                8       17                                        1    0.7    9     4.5    0.000
  Hypothyroidism        4       8.5                                       3    2      7     3.5    0.55
  Dyslipidemia          1       2.1                                       5    3.3    6     3      1.000
  Smoking/alcohol use   2       4.3                                       6    3.9    8     4      1.000
  Others                3       6.4                                       21   13.8   24    12.1   0.208

*Source*: Authors.

IHD, ischemic heart disease; NIHD, non-ischemic heart disease; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; SAH, hypertension; CRF, chronic renal failure.

Chi-squared test and Fisher\'s exact test.

###### 

Comparison of the study variables between the survival and death groups.

Table 4

  Variable                      Response           Group   *p*[a](#tblfn0020){ref-type="table-fn"}                               
  ----------------------------- ------------------ ------- ----------------------------------------- ------ ------ ------ ------ -------
  Fracture                      Femoral neck       22      46.8                                      53     34.9   75     37.7   0.450
  Trochanteric                  22                 46.8    91                                        59.9   113    56.8          
  Subtrochanteric               3                  6.4     7                                         4.6    10     5             
  Femoral neck + trochanteric   --                 --      1                                         7      1      0.5           
  Time of fracture/surgery      Up to 7 days       5       10.6                                      29     19.1   34     17.1   0.352
  8--15 days                    20                 42.6    64                                        42.1   84     42.2          
  Over 15 days                  22                 46.8    59                                        38.8   81     40.7          
  Time of fracture/admission    Up to 7 days       35      74.5                                      104    68.4   139    69.8   0.578
  8--15 days                    9                  19.1    41                                        27     50     25.1          
  Over 15 days                  3                  6.4     7                                         4.6    10     5             
  Time of fracture/discharge    Up to 15 days      7       15.6                                      48     31.6   55     27.9   0.18
  16--30 days                   23                 51.1    79                                        52     102    51.8          
  Over 30 days                  15                 33.3    25                                        16.4   40     20.3          
  Time of surgery/discharge     Up to 7 days       25      55.6                                      123    80.9   148    75.1   0.3
  8--15 days                    11                 24.4    15                                        9.9    26     13.2          
  Over 15 days                  9                  20      14                                        9.2    23     11.7          
  Osteosynthesis                DCS                9       19.1                                      15     9.9    24     12.1   0.11
                                DHS                14      29.8                                      71     46.7   85     42.7   
                                Cannulated screw   --      --                                        5      3.3    5      2.5    
                                PFN                1       2.1                                       9      5.9    10     5      
                                Short PFN          2       4.3                                       5      3.3    7      3.5    
                                Cemented PHR       8       17                                        9      5.9    17     8.5    
                                Cementless PHR     6       12.8                                      4      2.6    10     5      
                                Cemented THR       2       4.3                                       11     7.2    13     6.5    
                                Cementless THR     5       10.6                                      22     14.5   27     13.6   

*Source*: Authors.

DCS, dynamic condylar screw; DHS, dynamic hip screw; PFN, proximal femur nail; PHR, partial hip replacement; THR, total hip replacement.

Chi-squared test and Fisher\'s exact test.

###### 

Comparison between the survival and death groups according to the presence of complications in the postoperative period.

Table 5

  Complications                        Group   *p*[a](#tblfn0025){ref-type="table-fn"}                           
  ------------------------------------ ------- ----------------------------------------- ---- ------ ---- ------ -------
  UTI                                  3       6.4                                       17   11.2   20   10.1   0.418
  BPN                                  6       12.8                                      11   7.2    17   8.5    0.370
  SSI                                  4       8.5                                       7    4.6    11   5.5    0.464
  Osteosynthesis infection             1       2.1                                       2    1.3    3    1.5    1.000
  Osteosynthesis rupture/dislocation   1       2.1                                       5    3.3    6    3      1.000
  *Delirium*                           2       4.3                                       5    3.3    7    3.5    1.000
  Sepsis without focus                 8       17                                        3    2      11   5.5    0.001
  ARF                                  1       2.1                                       3    2      4    2      1.000
  Anemia                               1       2.1                                       5    3.3    6    3      1.000
  PTB                                  3       6.4                                       2    1.3    5    2      0.87
  Others                               3       6.4                                       3    2      6    3      0.145

*Source*: Authors.

BPN, bronchopneumonia; SSI, surgical site infection; ARF, acute renal failure; UTI, urinary tract infection; PTB, pulmonary thromboembolism.

Chi-squared test.
